PeptiDream to Codevelop Lilly's Alzheimer’s Diagnostic Tauvid in Japan

November 25, 2022
PeptiDream said on November 24 that its subsidiary PDRadiopharma has inked a deal with Eli Lilly to jointly develop flortaucipir ( 18 F), a PET scan imaging agent for detecting the level of tau proteins associated with Alzheimer’s, in Japan...read more